128 related articles for article (PubMed ID: 26640559)
21. The effect of combination of recombinant human bone morphogenetic protein-2 and basic fibroblast growth factor or insulin-like growth factor-I on dental implant osseointegration by confocal laser scanning microscopy.
Lan J; Wang Z; Wang Y; Wang J; Cheng X
J Periodontol; 2006 Mar; 77(3):357-63. PubMed ID: 16512749
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of recombinant human bone morphogenetic protein-2/calcium phosphate matrix for closed tibial diaphyseal fracture: a double-blind, randomized, controlled phase-II/III trial.
Lyon T; Scheele W; Bhandari M; Koval KJ; Sanchez EG; Christensen J; Valentin A; Huard F
J Bone Joint Surg Am; 2013 Dec; 95(23):2088-96. PubMed ID: 24306695
[TBL] [Abstract][Full Text] [Related]
23. The merit of sintered PDLLA/TCP composites in management of bone fracture internal fixation.
Lin FH; Chen TM; Lin CP; Lee CJ
Artif Organs; 1999 Feb; 23(2):186-94. PubMed ID: 10027889
[TBL] [Abstract][Full Text] [Related]
24. Effects of rhBMP-2 on cortical strut allograft healing to the femur in revision total hip arthroplasties: an experimental study.
Wu LD; Xiong Y; Yu HC
Int Orthop; 2007 Oct; 31(5):605-11. PubMed ID: 17123081
[TBL] [Abstract][Full Text] [Related]
25. BMP-2 delivered from a self-crosslinkable CaP/hydrogel construct promotes bone regeneration in a critical-size segmental defect model of non-union in dogs.
Minier K; Touré A; Fusellier M; Fellah B; Bouvy B; Weiss P; Gauthier O
Vet Comp Orthop Traumatol; 2014; 27(6):411-21. PubMed ID: 25327869
[TBL] [Abstract][Full Text] [Related]
26. Bone morphogenetic proteins - 7 and - 2 in the treatment of delayed osseous union secondary to bacterial osteitis in a rat model.
Helbig L; Omlor GW; Ivanova A; Guehring T; Sonntag R; Kretzer JP; Minkwitz S; Wildemann B; Schmidmaier G
BMC Musculoskelet Disord; 2018 Jul; 19(1):261. PubMed ID: 30049273
[TBL] [Abstract][Full Text] [Related]
27. The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model.
Jones AA; Buser D; Schenk R; Wozney J; Cochran DL
J Periodontol; 2006 Jul; 77(7):1184-93. PubMed ID: 16805681
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation.
Aro HT; Govender S; Patel AD; Hernigou P; Perera de Gregorio A; Popescu GI; Golden JD; Christensen J; Valentin A
J Bone Joint Surg Am; 2011 May; 93(9):801-8. PubMed ID: 21454742
[TBL] [Abstract][Full Text] [Related]
29. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients.
Govender S; Csimma C; Genant HK; Valentin-Opran A; Amit Y; Arbel R; Aro H; Atar D; Bishay M; Börner MG; Chiron P; Choong P; Cinats J; Courtenay B; Feibel R; Geulette B; Gravel C; Haas N; Raschke M; Hammacher E; van der Velde D; Hardy P; Holt M; Josten C; Ketterl RL; Lindeque B; Lob G; Mathevon H; McCoy G; Marsh D; Miller R; Munting E; Oevre S; Nordsletten L; Patel A; Pohl A; Rennie W; Reynders P; Rommens PM; Rondia J; Rossouw WC; Daneel PJ; Ruff S; Rüter A; Santavirta S; Schildhauer TA; Gekle C; Schnettler R; Segal D; Seiler H; Snowdowne RB; Stapert J; Taglang G; Verdonk R; Vogels L; Weckbach A; Wentzensen A; Wisniewski T;
J Bone Joint Surg Am; 2002 Dec; 84(12):2123-34. PubMed ID: 12473698
[TBL] [Abstract][Full Text] [Related]
30. [Internal fixation for zygomatic arch fracture with super-high molecular weight poly D, L-lactic acid mini-plates and screws: a study in dogs].
Wei S; Zheng Q; Zhao Z; Liu L; Li S; Wang H; Xiong C; Deng X; Luo F; Luo C
Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Feb; 17(1):63-5. PubMed ID: 12539327
[TBL] [Abstract][Full Text] [Related]
31. Hydrogel-based Delivery of rhBMP-2 Improves Healing of Large Bone Defects Compared With Autograft.
Krishnan L; Priddy LB; Esancy C; Li MT; Stevens HY; Jiang X; Tran L; Rowe DW; Guldberg RE
Clin Orthop Relat Res; 2015 Sep; 473(9):2885-97. PubMed ID: 25917422
[TBL] [Abstract][Full Text] [Related]
32. Action of recombinant human BMP-2 on fracture healing in rabbits is dependent on the mechanical environment.
Cuenca-López MD; Peris JL; García-Roselló M; Atienza C; Prat J; Becerra J; Andrades JA
J Tissue Eng Regen Med; 2010 Oct; 4(7):543-52. PubMed ID: 20209659
[TBL] [Abstract][Full Text] [Related]
33. Repair of ulnar segmental defect by recombinant human bone morphogenetic protein-2 in dogs.
Itoh T; Mochizuki M; Nishimura R; Matsunaga S; Kadosawa T; Kokubo S; Yokota S; Sasaki N
J Vet Med Sci; 1998 Apr; 60(4):451-8. PubMed ID: 9592717
[TBL] [Abstract][Full Text] [Related]
34. Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) for the Treatment of Nonunion of the Femur in Children and Adolescents: A Retrospective Analysis.
Hissnauer TN; Stiel N; Babin K; Rupprecht M; Ridderbusch K; Rueger JM; Stuecker R; Spiro AS
Biomed Res Int; 2017; 2017():3046842. PubMed ID: 28349058
[No Abstract] [Full Text] [Related]
35. Comparative study suggests that human bone morphogenetic proteins have no influence on the outcome of operative treatment of aseptic clavicle non-unions.
von Rüden C; Morgenstern M; Friederichs J; Augat P; Hackl S; Woltmann A; Bühren V; Hierholzer C
Int Orthop; 2016 Nov; 40(11):2339-2345. PubMed ID: 27520739
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of fracture healing by local application of humoral factors integrated in biodegradable implants.
Illi OE; Feldmann CP
Eur J Pediatr Surg; 1998 Aug; 8(4):251-5. PubMed ID: 9783152
[TBL] [Abstract][Full Text] [Related]
37. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model.
Welch RD; Jones AL; Bucholz RW; Reinert CM; Tjia JS; Pierce WA; Wozney JM; Li XJ
J Bone Miner Res; 1998 Sep; 13(9):1483-90. PubMed ID: 9738522
[TBL] [Abstract][Full Text] [Related]
38. Antigen-extracted xenogeneic cancellous bone graft with recombinant human bone morphogenetic protein-2 enhances bone regeneration in repair of mandibular defect in rabbits.
Li ZJ; Lu CT; Feng ZQ; Zhao QT; Zhou ZY; Lai RF
Kaohsiung J Med Sci; 2015 Jan; 31(1):18-25. PubMed ID: 25600916
[TBL] [Abstract][Full Text] [Related]
39. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo.
Boyan BD; Lohmann CH; Somers A; Niederauer GG; Wozney JM; Dean DD; Carnes DL; Schwartz Z
J Biomed Mater Res; 1999 Jul; 46(1):51-9. PubMed ID: 10357135
[TBL] [Abstract][Full Text] [Related]
40. Assessment of bone healing after Le Fort I osteotomy with 3-dimensional computed tomography.
Ueki K; Miyazaki M; Okabe K; Mukozawa A; Marukawa K; Moroi A; Nakagawa K; Yamamoto E
J Craniomaxillofac Surg; 2011 Jun; 39(4):237-43. PubMed ID: 20705473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
